期刊文献+

ApoA5基因单核苷酸多态性与代谢综合征的相关性 被引量:3

Relationship between ApoA5 gene polymorphisms and metabolic syndrome
下载PDF
导出
摘要 目的探讨ApoA5基因单核苷酸多态性与代谢综合征的关系。方法随机选取2012年1月至2013年1月在我校附属医院接受治疗的100例代谢综合征(MS)患者,并采用1:1匹配设计选取100例正常人为研究对象。采用PCR-RFLP分析ApoA5基因-1131T>C和56C>G两个SNP位点单核苷酸多态性与代谢综合征的关系。结果 ApoA5-1131T>C CC基因型携带者的TG、HDL-C、ApoA1的水平明显高于TC、TT基因型携带者,差异有统计学意义(P<0.05)。而ApoA5 56C>G各基因型之间MS患者的临床及生化指标差异均无统计学意义(P>0.05)。ApoA5-1131T>C TC基因型携带者比CC基因型携带者更容易发生MS,风险分别上升1.415倍,而TT型基因携带者发生MS的风险为CC型的0.302倍(P<0.05)。结论 ApoA5-1131T>C的基因多态性与MS的发生密切相关,可增加MS发病率,而ApoA5 56C>G的基因多态性与MS的发生无显著相关。 Objective To explore the relationship between metabolic syndrome and ApoA5 gene polymor- phism. Methods One hundred patients with metabolic syndrome (MS) matched with 100 healthy subjects were se- lected randomly from January 2012 to January 2013 in the Affiliated Hospital of Huaihua Medical College. PCR-RFLP was used to analyze if there was a correlation between the single nucleotide polymorphisms of ApoA5 gene-ll31T〉C and 56C〉G SNP and metabolic syndrome. Results The levels ofTG, HDL-C, ApoA1 of subjects with ApoA5-1131T〉C CC genotype were significantly higher than those of subjects with TC and TT genotype (P〈 0.05). The clinical and biochemical parameters showed no significant difference between MS patients with ApoA5 56C〉G genotypes (P〉0.05). ApoA5-1131T〉C TC genotype increased the risk of developing MS by 1.415, but TT gcno- type decreased the risk of developing MS comparing to CC genotype by 0.302 (P〈0.05). Conclusion The SNP of ApoA5-1131T〉C is closely related to the occurrence of MS and can increase the risk of MS, while SNP of ApoA5 56C〉G has no relationship with the occurrence of MS.
出处 《海南医学》 CAS 2013年第22期3281-3285,共5页 Hainan Medical Journal
基金 2012年湖南省教育厅科研项目(编号:12C1195)
关键词 基因多态性 载脂蛋白A5 代谢综合征 SNP ApoAS Metabolic syndrome
  • 相关文献

参考文献16

  • 1Eckel RH,Grundy SM,Zimmet PZ. The metabolic syndrome[J].{H}LANCET,2005.1415-1428.
  • 2唐永忠,王萍.肥胖与高血压、高脂血症、高血糖的相关性[J].海南医学,2008,19(11):56-56. 被引量:12
  • 3姚丽丽,朱晓晖,王军,崔世维.2型糖尿病患者体表指标与代谢综合征及胰岛B细胞功能的关系[J].海南医学,2010,21(20):12-14. 被引量:5
  • 4Chan DC,Barret PH,Watts GF. Recent studies of lipoprotein kinetics in the metabolic syndrome and related disorders[J].{H}CURRENT OPINION IN LIPIDOLOGY,2006.28-36.
  • 5O'Brien PJ,Alborn WE,Sloan JH. The novel apolipoprotein A5 is present in human serum,is associated with VLDL,HDL,and chylomicrons,and circulates at very low concentrations compared with other apolipoproteins[J].{H}Clinical Chemistry,2005.351-359.
  • 6Sima A,Iordan A,Stancu C. Apolipoprotein e polymorphism-a risk factor for metabolic syndrome[J].{H}Clinical Chemistry and Laboratory Medicine,2007,(09):1149-1153.
  • 7Sierra-Johnson J,Somers VK,Ktniyoshi FH. Comparison of apolipoprotein-b/apolipoprotein-ai in subjects with versus without the metabolic syndrome[J].{H}American Journal of Cardiology,2006,(10):1369-1373.
  • 8Cardona F,Morcillo S,Gonzalo-Marin M. The apolipoprotein e genotype predicts postprandial hypertriglyceridemia in patients with the metabolic syndrome[J].{H}Journal of Clinical Endocrinology and Metabolism,2005,(05):2972-2975.
  • 9Ong KL,Jiang CQ,Liu B. Association of a genetic variant in the apolipoprotein a5 gene with the metabolic syndrome in Chinese[J].{H}Clinical Endocrinology(Oxford),2011,(02):206-213.
  • 10Kisfali P,Mohas M,Maasz A. Haplotype analysis of the apolipoprotein a5 gene in patients with the metabolic syndrome[J].{H}Nutrition Metabolism and Cardiovascular Diseases,2011,(07):505-511.

二级参考文献10

共引文献15

同被引文献21

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部